279 related articles for article (PubMed ID: 35414500)
21. LncRNA PCAT6 promotes the proliferation, migration and invasion of pancreatic ductal adenocarcinoma via regulating miR-185-5p/CBX2 axis.
Wang W; Li X; Guan C; Hu Z; Zhao Y; Li W; Jiang X
Pathol Res Pract; 2020 Sep; 216(9):153074. PubMed ID: 32825947
[TBL] [Abstract][Full Text] [Related]
22. miR-615-5p is epigenetically inactivated and functions as a tumor suppressor in pancreatic ductal adenocarcinoma.
Gao W; Gu Y; Li Z; Cai H; Peng Q; Tu M; Kondo Y; Shinjo K; Zhu Y; Zhang J; Sekido Y; Han B; Qian Z; Miao Y
Oncogene; 2015 Mar; 34(13):1629-40. PubMed ID: 24769899
[TBL] [Abstract][Full Text] [Related]
23. Gene regulation by antitumor miR-130b-5p in pancreatic ductal adenocarcinoma: the clinical significance of oncogenic EPS8.
Fukuhisa H; Seki N; Idichi T; Kurahara H; Yamada Y; Toda H; Kita Y; Kawasaki Y; Tanoue K; Mataki Y; Maemura K; Natsugoe S
J Hum Genet; 2019 Jun; 64(6):521-534. PubMed ID: 30858505
[TBL] [Abstract][Full Text] [Related]
24. ZFP36L2 promotes cancer cell aggressiveness and is regulated by antitumor microRNA-375 in pancreatic ductal adenocarcinoma.
Yonemori K; Seki N; Kurahara H; Osako Y; Idichi T; Arai T; Koshizuka K; Kita Y; Maemura K; Natsugoe S
Cancer Sci; 2017 Jan; 108(1):124-135. PubMed ID: 27862697
[TBL] [Abstract][Full Text] [Related]
25. MiR-497 inhibits cell proliferation and invasion ability by targeting HMGA2 in pancreatic ductal adenocarcinoma.
Zhou ZG; Xu C; Dong Z; Wang YP; Duan JY; Yan CQ
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):122-129. PubMed ID: 31957824
[TBL] [Abstract][Full Text] [Related]
26. miRNA-1290 Promotes Aggressiveness in Pancreatic Ductal Adenocarcinoma by Targeting IKK1.
Ta N; Huang X; Zheng K; Zhang Y; Gao Y; Deng L; Zhang B; Jiang H; Zheng J
Cell Physiol Biochem; 2018; 51(2):711-728. PubMed ID: 30463064
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S
Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446
[TBL] [Abstract][Full Text] [Related]
28. RELA/NEAT1/miR-302a-3p/RELA feedback loop modulates pancreatic ductal adenocarcinoma cell proliferation and migration.
Luo Z; Yi ZJ; Ou ZL; Han T; Wan T; Tang YC; Wang ZC; Huang FZ
J Cell Physiol; 2019 Apr; 234(4):3583-3597. PubMed ID: 30362505
[TBL] [Abstract][Full Text] [Related]
29. MiR-377 inhibits the proliferation of pancreatic cancer by targeting Pim-3.
Chang W; Liu M; Xu J; Fu H; Zhou B; Yuan T; Chen P
Tumour Biol; 2016 Nov; 37(11):14813-14824. PubMed ID: 27638830
[TBL] [Abstract][Full Text] [Related]
30. miRNA-193b-5p Suppresses Pancreatic Cancer Cell Proliferation, Invasion, Epithelial Mesenchymal Transition, and Tumor Growth by Inhibiting eEF2K.
Gurbuz N; Kahraman N; Sonmez HE; Mokhlis HA; Kosar PA; Ozpolat B
Anticancer Agents Med Chem; 2022; 22(14):2607-2618. PubMed ID: 35718922
[TBL] [Abstract][Full Text] [Related]
31. MiR-7-5p functions as a tumor suppressor by targeting SOX18 in pancreatic ductal adenocarcinoma.
Zhu W; Wang Y; Zhang D; Yu X; Leng X
Biochem Biophys Res Commun; 2018 Mar; 497(4):963-970. PubMed ID: 29408481
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of microRNA-141 expression and its tumor suppressor function in human pancreatic ductal adenocarcinoma.
Zhu ZM; Xu YF; Su QJ; Du JD; Tan XL; Tu YL; Tan JW; Jiao HB
Mol Cell Biochem; 2014 Mar; 388(1-2):39-49. PubMed ID: 24242138
[TBL] [Abstract][Full Text] [Related]
33. The MYEOV-MYC association promotes oncogenic miR-17/93-5p expression in pancreatic ductal adenocarcinoma.
Shen H; Ye F; Xu D; Fang L; Zhang X; Zhu J
Cell Death Dis; 2021 Dec; 13(1):15. PubMed ID: 34930894
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-122-5p inhibits cell proliferation, migration and invasion by targeting CCNG1 in pancreatic ductal adenocarcinoma.
Dai C; Zhang Y; Xu Z; Jin M
Cancer Cell Int; 2020; 20():98. PubMed ID: 32256207
[TBL] [Abstract][Full Text] [Related]
35. Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-β signaling pathway.
Yin Z; Ma T; Huang B; Lin L; Zhou Y; Yan J; Zou Y; Chen S
J Exp Clin Cancer Res; 2019 Jul; 38(1):310. PubMed ID: 31307515
[TBL] [Abstract][Full Text] [Related]
36. Role of miR-214-5p in the migration and invasion of pancreatic cancer cells.
Cao TH; Ling X; Chen C; Tang W; Hu DM; Yin GJ
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7214-7221. PubMed ID: 30468464
[TBL] [Abstract][Full Text] [Related]
37. Repression of circRNA_000684 inhibits malignant phenotypes of pancreatic ductal adenocarcinoma cells via miR-145-mediated KLF5.
Liu X; Zhong L; Jiang W; Wen D
Pancreatology; 2021 Mar; 21(2):406-417. PubMed ID: 33563550
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-135a inhibits cell proliferation by targeting Bmi1 in pancreatic ductal adenocarcinoma.
Dang Z; Xu WH; Lu P; Wu N; Liu J; Ruan B; Zhou L; Song WJ; Dou KF
Int J Biol Sci; 2014; 10(7):733-45. PubMed ID: 25013381
[TBL] [Abstract][Full Text] [Related]
39. LINC00460 promotes pancreatic cancer progression by sponging miR-491-5p.
Wu J; Sun S; Liao W; Chen E; Wang X; Song Y; Duan F; Deng W; Li S
J Gene Med; 2021 Jun; 23(6):e3333. PubMed ID: 33789360
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-21 in pancreatic ductal adenocarcinoma tumor-associated fibroblasts promotes metastasis.
Kadera BE; Li L; Toste PA; Wu N; Adams C; Dawson DW; Donahue TR
PLoS One; 2013; 8(8):e71978. PubMed ID: 23991015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]